Advanced breast cancer: A randomized study of doxorubicin or mitoxantrone in combination with cyclophosphamide and vincristine
- 1 June 1996
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 39 (2) , 155-163
- https://doi.org/10.1007/bf01806182
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Breast cancer: Chemotherapy in the treatment of advanced diseaseEuropean Journal Of Cancer, 1993
- Randomized Trial of Doxorubicin, Bisantrene, and Miltoxantrone in Advanced Breast Cancer: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1991
- New Cytotoxic Drugs in Treatment of Breast CancerActa Oncologica, 1990
- Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.Journal of Clinical Oncology, 1989
- A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.Journal of Clinical Oncology, 1988
- Mitoxantrone, cyclophosphamide, and fluorouracil in metastatic breast cancer unresponsive to hormonal therapyCancer, 1987
- Patient treatment preference in advanced breast cancer: A randomized cross-over study of doxorubicin and mitozantroneEuropean Journal of Cancer and Clinical Oncology, 1987
- A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancerInvestigational New Drugs, 1985
- Mitoxantrone: an overview of safety and toxicityInvestigational New Drugs, 1985
- Mitoxantrone for the treatment of advanced breast cancer: Single-agent therapy in previously untreated patientsEuropean Journal of Cancer and Clinical Oncology, 1984